165 related articles for article (PubMed ID: 34198299)
1. Relationship between Renal Damage and Serum Complement C3 in Children with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis.
Zhang P; Yang X; He X; Hu J; Gao CL; Xia ZK
Nephron; 2021; 145(6):633-641. PubMed ID: 34198299
[TBL] [Abstract][Full Text] [Related]
2. Complement Components C3 and C4 Indicate Vasculitis Manifestations to Distinct Renal Compartments in ANCA-Associated Glomerulonephritis.
Hakroush S; Tampe D; Korsten P; Ströbel P; Tampe B
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34205415
[TBL] [Abstract][Full Text] [Related]
3. Low Serum Complement C3 Levels at Diagnosis of Renal ANCA-Associated Vasculitis Is Associated with Poor Prognosis.
Augusto JF; Langs V; Demiselle J; Lavigne C; Brilland B; Duveau A; Poli C; Chevailler A; Croue A; Tollis F; Sayegh J; Subra JF
PLoS One; 2016; 11(7):e0158871. PubMed ID: 27391243
[TBL] [Abstract][Full Text] [Related]
4. Association of Serum C3 Concentration and Histologic Signs of Thrombotic Microangiopathy with Outcomes among Patients with ANCA-Associated Renal Vasculitis.
Manenti L; Vaglio A; Gnappi E; Maggiore U; Allegri L; Allinovi M; Urban ML; Delsante M; Galetti M; Nicastro M; Pilato FP; Buzio C
Clin J Am Soc Nephrol; 2015 Dec; 10(12):2143-51. PubMed ID: 26542163
[TBL] [Abstract][Full Text] [Related]
5. Hypocomplementemia is associated with more severe renal disease and worse renal outcomes in patients with ANCA-associated vasculitis: a retrospective cohort study.
Chalkia A; Thomas K; Giannou P; Panagiotopoulos A; Hadziyannis E; Kapota A; Gakiopoulou H; Vassilopoulos D; Petras D
Ren Fail; 2020 Nov; 42(1):845-852. PubMed ID: 32787590
[TBL] [Abstract][Full Text] [Related]
6. Implication of platelets and complement C3 as link between innate immunity and tubulointerstitial injury in renal vasculitis with MPO-ANCA seropositivity.
Baier E; Tampe D; Kluge IA; Hakroush S; Tampe B
Front Immunol; 2022; 13():1054457. PubMed ID: 36439156
[TBL] [Abstract][Full Text] [Related]
7. Serum C3 complement levels in ANCA associated vasculitis at diagnosis is a predictor of patient and renal outcome.
Crnogorac M; Horvatic I; Kacinari P; Ljubanovic DG; Galesic K
J Nephrol; 2018 Apr; 31(2):257-262. PubMed ID: 29027625
[TBL] [Abstract][Full Text] [Related]
8. Complement in ANCA-associated glomerulonephritis.
Hilhorst M; van Paassen P; van Rie H; Bijnens N; Heerings-Rewinkel P; van Breda Vriesman P; Cohen Tervaert JW;
Nephrol Dial Transplant; 2017 Aug; 32(8):1302-1313. PubMed ID: 26275893
[TBL] [Abstract][Full Text] [Related]
9. The influence of cathelicidin LL37 in human anti-neutrophils cytoplasmic antibody (ANCA)-associated vasculitis.
Zhang Y; Shi W; Tang S; Li J; Yin S; Gao X; Wang L; Zou L; Zhao J; Huang Y; Shan L; Gounni AS; Wu Y; Yuan F; Zhang J
Arthritis Res Ther; 2013 Oct; 15(5):R161. PubMed ID: 24286516
[TBL] [Abstract][Full Text] [Related]
10. Increased renal damage in hypocomplementemic patients with ANCA-associated vasculitis: retrospective cohort study.
García L; Pena CE; Maldonado RÁ; Costi C; Mamberti M; Martins E; García MA
Clin Rheumatol; 2019 Oct; 38(10):2819-2824. PubMed ID: 31222573
[TBL] [Abstract][Full Text] [Related]
11. Association of low serum complement C3 with reduced patient and renal survival in antimyeloperoxidase-associated small-vessel vasculitis.
Molad Y; Tovar A; Ofer-Shiber S
Nephron Clin Pract; 2014; 126(1):67-74. PubMed ID: 24577364
[TBL] [Abstract][Full Text] [Related]
12. [Retrospective clinical features and renal pathological analysis of 15 children with anti-neutrophil cytoplasmic antibody-associated vasculitis].
Guan N; Yao Y; Yang JY; Xiao HJ; Ding J
Zhonghua Er Ke Za Zhi; 2013 Apr; 51(4):283-7. PubMed ID: 23927802
[TBL] [Abstract][Full Text] [Related]
13. Low serum complement 3 level is associated with severe ANCA-associated vasculitis at diagnosis.
Choi H; Kim Y; Jung SM; Song JJ; Park YB; Lee SW
Clin Exp Nephrol; 2019 Feb; 23(2):223-230. PubMed ID: 30168048
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and prognostic risk factors of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV).
Chen Z; Lin L; Yang W; Chen N; Lin Y
Int Immunopharmacol; 2020 Oct; 87():106819. PubMed ID: 32717565
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for renal outcomes in children with antineutrophil cytoplasmic antibody-associated vasculitis: a nationwide retrospective study in China.
Tan LW; Wan JL; Zhu CH; Xu H; Xia ZK; Chen LZ; Wu XC; Wang F; Liu XR; Zhao CG; Li XZ; Mao JH; Wang XW; Huang WY; Li YH; Zhang JJ; Feng SP; Yang J; Liu JJ; Gao CL; Rong LP; Shuai LJ; Xu K; Zhang HJ; Li Q; Zhang AH; Wang M
World J Pediatr; 2024 May; 20(5):506-516. PubMed ID: 37853276
[TBL] [Abstract][Full Text] [Related]
16. Glomerular Immune Deposition in MPO-ANCA Associated Glomerulonephritis Is Associated With Poor Renal Survival.
Lin W; Shen C; Zhong Y; Ooi JD; Eggenhuizen P; Zhou YO; Luo H; Huang J; Chen JB; Wu T; Meng T; Xiao Z; Ao X; Peng W; Tang R; Yin H; Xiao X; Zhou Q; Xiao P
Front Immunol; 2021; 12():625672. PubMed ID: 33841408
[TBL] [Abstract][Full Text] [Related]
17. Antineutrophilic cytoplasmic antibody-associated vasculitis with and without renal involvement: C3 contributes to prognosis, but renal involvement does not.
Fukui S; Iwamoto N; Takatani A; Igawa T; Shimizu T; Umeda M; Nishino A; Koga T; Kawashiri SY; Tamai M; Ichinose K; Nakamura H; Origuchi T; Sato S; Kawakami A
Int J Rheum Dis; 2019 May; 22(5):789-796. PubMed ID: 30398012
[TBL] [Abstract][Full Text] [Related]
18. Systemic complement activation in anti-neutrophil cytoplasmic antibody-associated vasculitis and necrotizing glomerulonephritis.
Bantis K; Stangou M; Kalpakidis S; Hatziadamou M; Daikidou DV; Lioulios G; Mitsoglou Z; Chatzidrosou H; Nikolaidou C; Fylaktou A; Papagianni A
Nephrology (Carlton); 2021 Jan; 26(1):30-37. PubMed ID: 32602136
[TBL] [Abstract][Full Text] [Related]
19. Antineutrophilic cytoplasmic antibody-associated vasculitis with hypocomplementemia has a higher incidence of serious organ damage and a poor prognosis.
Fukui S; Iwamoto N; Umeda M; Nishino A; Nakashima Y; Koga T; Kawashiri SY; Ichinose K; Hirai Y; Tamai M; Nakamura H; Origuchi T; Sato S; Kawakami A
Medicine (Baltimore); 2016 Sep; 95(37):e4871. PubMed ID: 27631255
[TBL] [Abstract][Full Text] [Related]
20. The risk factors for early mortality and end-stage renal disease in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis: experiences from a single center.
Ni A; Chen L; Huang X; Ma Y; Lan L; Ren P; Wang Y; Zhu Y; Xu Y; Chen J; Han F
Clin Exp Med; 2021 Aug; 21(3):389-397. PubMed ID: 33768341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
